Corteva (CTVA) Stock Forecast & Price Target

$62.30 +0.67 (+1.08%)

As of 01/17/2025 03:59 PM Eastern

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
4

Buy
14

Based on 19 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 4 have given a hold rating, and 14 have given a buy rating for CTVA.

Consensus Price Target

$65.47
5.10% Upside

According to the 19 analysts' twelve-month price targets for Corteva, the average price target is $65.47. The highest price target for CTVA is $73.00, while the lowest price target for CTVA is $53.00. The average price target represents a forecasted upside of 5.10% from the current price of $62.30.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

CTVA Analyst Ratings Over Time

Type	Current Forecast 1/21/24 to 1/20/25	1 Month Ago 12/22/23 to 12/21/24	3 Months Ago 10/23/23 to 10/22/24	1 Year Ago 1/21/23 to 1/21/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$65.47	$65.41	$62.21	$64.32
Forecasted Upside	5.10% Upside	13.80% Upside	5.23% Upside	41.04% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.68	2.49	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	5.10% Upside	46.10% Upside	12.44% Upside
News Sentiment Rating	Positive News See Recent CTVA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/10/2025	UBS Group 4 of 5 stars	Joshua Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$74.00 ➝ $73.00	+27.56%
1/10/2025	KeyCorp 3 of 5 stars	Aleksey Yefremov Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$69.00 ➝ $68.00	+20.57%
12/19/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$68.00 ➝ $73.00	+29.25%
12/18/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Cunningham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$70.00 ➝ $69.00	+17.33%
11/20/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$67.00 ➝ $69.00	+18.97%
11/20/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$65.00 ➝ $67.00	+15.52%
11/8/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$58.00 ➝ $62.00	+5.93%
11/8/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$69.00 ➝ $70.00	+18.02%
9/24/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$65.00 ➝ $65.00	+12.67%
8/7/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Selesky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
8/2/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$57.00 ➝ $55.00	+6.63%
6/18/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$61.00 ➝ $60.00	+15.27%
6/12/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$65.00 ➝ $65.00	+25.90%
6/7/2024	OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Mixed ➝ Negative
5/3/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $65.00	+13.72%
5/3/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$64.00 ➝ $67.00	+17.13%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$67.00	+25.30%
2/12/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$57.00 ➝ $65.00	+21.27%
2/2/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Neutral	$53.00	-1.96%
11/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$63.00 ➝ $52.00	+11.42%
11/22/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$82.00 ➝ $63.00	+36.45%
10/24/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$65.00 ➝ $56.00	+15.08%
8/4/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$74.00	+31.95%
7/25/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
5/22/2023	VNET Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Upgrade
5/22/2023	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$67.00	+17.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:09 PM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 19, 2025. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

Corteva, Inc. recently declared a quarterly dividend of $0.17, which translates to an annualized dividend of $0.68. This provides a dividend yield of 1.21%, offering a return to investors through regular income.
The company has announced a stock repurchase program authorizing the buyback of up to $3.00 billion in shares, indicating that the board believes the stock is undervalued. Such programs can enhance shareholder value by reducing the number of shares outstanding.
Corteva, Inc. has a strong institutional ownership, with 81.54% of its stock held by hedge funds and other institutional investors. This can be a positive indicator of confidence in the company's future performance.
The current stock price reflects a stable financial position, supported by a current ratio of 1.50, which suggests that the company can cover its short-term liabilities with its short-term assets.
The company operates in the agriculture sector, focusing on Seed and Crop Protection, which are essential for food production and can benefit from increasing global food demand.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

The payout ratio of 68.69% indicates that a significant portion of earnings is being distributed as dividends, which may limit the company's ability to reinvest in growth opportunities.
The quick ratio of 0.96 suggests that Corteva, Inc. may have difficulty meeting its short-term obligations without selling inventory, which could be a concern for liquidity.
While the stock repurchase program is a positive sign, it may also indicate that the company lacks better investment opportunities for growth, which could be a red flag for long-term investors.
Recent fluctuations in the agriculture market can impact Corteva's performance, as the company is heavily reliant on agricultural demand and pricing, which can be volatile.
The debt-to-equity ratio of 0.08 indicates low leverage, but it also suggests that the company may not be taking advantage of debt financing to fuel growth, potentially limiting expansion opportunities.

CTVA Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $65.47, with a high forecast of $73.00 and a low forecast of $53.00.
: 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There is currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CTVA shares.
: According to analysts, Corteva's stock has a predicted upside of 5.10% based on their 12-month stock forecasts.
: Corteva has been rated by research analysts at Bank of America, Barclays, Citigroup, KeyCorp, Oppenheimer, Royal Bank of Canada, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:CTVA) was last updated on 1/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target